CytomX Therapeutics, Inc. Operating Income
CytomX Therapeutics, Inc. (CTMX) reported Operating Income of -$23.78 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-08-06
- CytomX Therapeutics, Inc. operating income (loss) for the quarter ending 2026-06-30 was -$23.78M.
- CytomX Therapeutics, Inc. operating income (loss) for the quarter ending 2026-03-31 was -$19.67M, a 186.96% decline year-over-year.
- CytomX Therapeutics, Inc. operating income (loss) for the quarter ending 2025-12-31 was -$27.93M, a 258.00% decline year-over-year.
- CytomX Therapeutics, Inc. operating income (loss) for the quarter ending 2025-09-30 was -$15.77M, a 483.56% decline year-over-year.
- CytomX Therapeutics, Inc. operating income (loss) for fiscal 2025 was -$22.36M, a 189.47% decline from fiscal 2024.
- CytomX Therapeutics, Inc. operating income (loss) for fiscal 2024 was $25.00M.
- CytomX Therapeutics, Inc. operating income (loss) for fiscal 2023 was -$6.48M.
- CytomX Therapeutics, Inc. operating income (loss) for fiscal 2022 was -$101.33M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 3 month as first filed | Operating Income (Loss) 6 month | Operating Income (Loss) 6 month as first filed | Operating Income (Loss) 9 month | Operating Income (Loss) 9 month as first filed | Operating Income (Loss) 12 month | Operating Income (Loss) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$23.78M 10-Q · filed 2026-08-06 | -$43.45M 10-Q · filed 2026-08-06 | -$71.39M derived: sum of 3 quarters · filed 2026-08-06 | -$87.15M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | -$19.67M 10-Q · filed 2026-05-07 | -$47.60M derived: sum of 2 quarters · filed 2026-05-07 | -$63.37M derived: sum of 3 quarters · filed 2026-05-07 | -$64.66M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | -$27.93M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | -$43.70M derived: sum of 2 quarters · filed 2026-03-16 | -$44.99M derived: sum of 3 quarters · filed 2026-08-06 | -$22.36M 10-K · filed 2026-03-16 | ||||
| 2025-09-30 | -$15.77M 10-Q · filed 2025-11-06 | -$17.05M derived: sum of 2 quarters · filed 2026-08-06 | $5.57M 10-Q · filed 2025-11-06 | $23.25M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | -$1.29M 10-Q · filed 2026-08-06 | $21.34M 10-Q · filed 2026-08-06 | $39.01M derived: sum of 3 quarters · filed 2026-08-06 | $43.13M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | $22.62M 10-Q · filed 2026-05-07 | $40.30M derived: sum of 2 quarters · filed 2026-05-07 | $44.41M derived: sum of 3 quarters · filed 2026-05-07 | $35.96M derived: sum of 4 quarters · filed 2026-05-07 | ||||
| 2024-12-31 | $17.68M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $21.79M derived: sum of 2 quarters · filed 2026-03-16 | $13.34M derived: sum of 3 quarters · filed 2026-03-16 | $25.00M 10-K · filed 2026-03-16 | ||||
| 2024-09-30 | $4.11M 10-Q · filed 2025-11-06 | -$4.34M derived: sum of 2 quarters · filed 2025-11-06 | $7.32M 10-Q · filed 2025-11-06 | $6.71M derived: sum of 4 quarters · filed 2025-11-06 | ||||
| 2024-06-30 | -$8.45M 10-Q · filed 2025-08-07 | $3.21M 10-Q · filed 2025-08-07 | $2.60M derived: sum of 3 quarters · filed 2025-08-07 | $5.72M derived: sum of 4 quarters · filed 2025-08-07 | ||||
| 2024-03-31 | $11.66M 10-Q · filed 2025-05-12 | $11.05M derived: sum of 2 quarters · filed 2025-05-12 | $14.17M derived: sum of 3 quarters · filed 2025-05-12 | $10.83M derived: sum of 4 quarters · filed 2025-05-12 | ||||
| 2023-12-31 | -$606.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | $2.52M derived: sum of 2 quarters · filed 2025-03-06 | -$831.00K derived: sum of 3 quarters · filed 2025-03-06 | -$6.48M 10-K · filed 2025-03-06 | ||||
| 2023-09-30 | $3.12M 10-Q · filed 2024-11-07 | -$225.00K derived: sum of 2 quarters · filed 2024-11-07 | -$5.88M 10-Q · filed 2024-11-07 | -$15.39M derived: sum of 4 quarters · filed 2024-11-07 | ||||
| 2023-06-30 | -$3.35M 10-Q · filed 2024-08-08 | -$9.00M 10-Q · filed 2024-08-08 | -$18.51M derived: sum of 3 quarters · filed 2024-08-08 | -$48.22M derived: sum of 4 quarters · filed 2024-08-08 | ||||
| 2023-03-31 | -$5.65M 10-Q · filed 2024-05-08 | -$15.16M derived: sum of 2 quarters · filed 2024-05-08 | -$44.87M derived: sum of 3 quarters · filed 2024-05-08 | -$74.92M derived: sum of 4 quarters · filed 2024-05-08 | ||||
| 2022-12-31 | -$9.51M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-11 | -$39.22M derived: sum of 2 quarters · filed 2024-03-11 | -$69.27M derived: sum of 3 quarters · filed 2024-03-11 | -$101.33M 10-K · filed 2024-03-11 | ||||
| 2022-09-30 | -$29.71M 10-Q · filed 2023-11-07 | -$23.94M 10-Q · filed 2022-11-08 | -$59.76M derived: sum of 2 quarters · filed 2023-11-07 | -$91.83M 10-Q · filed 2023-11-07 | -$72.65M 10-Q · filed 2022-11-08 | -$126.73M derived: sum of 4 quarters · filed 2023-11-07 | ||
| 2022-06-30 | -$30.05M 10-Q · filed 2023-08-08 | -$24.74M 10-Q · filed 2022-08-04 | -$62.12M 10-Q · filed 2023-08-08 | -$48.71M 10-Q · filed 2022-08-04 | -$97.02M derived: sum of 3 quarters · filed 2023-08-08 | -$128.06M derived: sum of 4 quarters · filed 2023-08-08 | ||
| 2022-03-31 | -$32.06M 10-Q · filed 2023-05-09 | -$23.97M 10-Q · filed 2022-05-05 | -$66.97M derived: sum of 2 quarters · filed 2023-05-09 | -$98.00M derived: sum of 3 quarters · filed 2023-05-09 | -$124.70M derived: sum of 4 quarters · filed 2023-05-09 | |||
| 2021-12-31 | -$34.90M 10-K/A · filed 2023-03-27 | -$65.94M derived: sum of 2 quarters · filed 2023-03-27 | -$92.64M derived: sum of 3 quarters · filed 2023-03-27 | -$116.04M 10-K/A · filed 2023-03-27 | -$83.78M 10-K · filed 2022-03-01 | |||
| 2021-09-30 | -$31.04M 10-K/A · filed 2023-03-27 | -$22.64M 10-Q · filed 2021-11-04 | -$57.74M derived: sum of 2 quarters · filed 2023-03-27 | -$81.14M 10-K/A · filed 2023-03-27 | -$57.47M 10-Q · filed 2021-11-04 | -$105.21M derived: sum of 4 quarters · filed 2023-03-27 | ||
| 2021-06-30 | -$26.70M 10-K/A · filed 2023-03-27 | -$19.20M 10-Q · filed 2021-08-05 | -$50.10M 10-K/A · filed 2023-03-27 | -$34.83M 10-Q · filed 2021-08-05 | -$74.17M derived: sum of 3 quarters · filed 2023-03-27 | -$99.39M derived: sum of 4 quarters · filed 2023-03-27 | ||
| 2021-03-31 | -$23.40M 10-K/A · filed 2023-03-27 | -$15.63M 10-Q · filed 2021-05-06 | -$47.48M derived: sum of 2 quarters · filed 2023-03-27 | -$72.69M derived: sum of 3 quarters · filed 2023-03-27 | -$98.45M derived: sum of 4 quarters · filed 2023-03-27 | |||
| 2020-12-31 | -$24.07M 10-K/A · filed 2023-03-27 | -$49.29M derived: sum of 2 quarters · filed 2023-03-27 | -$75.05M derived: sum of 3 quarters · filed 2023-03-27 | -$80.54M 10-K/A · filed 2023-03-27 | -$48.60M 10-K · filed 2021-02-24 | |||
| 2020-09-30 | -$25.22M 10-K/A · filed 2023-03-27 | -$14.89M 10-Q · filed 2020-11-05 | -$50.98M derived: sum of 2 quarters · filed 2023-03-27 | -$56.47M 10-K/A · filed 2023-03-27 | -$33.83M 10-Q · filed 2020-11-05 | -$124.43M derived: sum of 4 quarters · filed 2023-03-27 | ||
| 2020-06-30 | -$25.76M 10-K/A · filed 2023-03-27 | -$16.14M 10-Q · filed 2020-08-06 | -$31.25M 10-K/A · filed 2023-03-27 | -$18.93M 10-Q · filed 2020-08-06 | -$99.22M derived: sum of 3 quarters · filed 2023-03-27 | -$124.93M derived: sum of 4 quarters · filed 2023-03-27 | ||
| 2020-03-31 | -$5.49M 10-K/A · filed 2023-03-27 | -$2.79M 10-Q · filed 2020-05-07 | -$73.46M derived: sum of 2 quarters · filed 2023-03-27 | -$99.17M derived: sum of 3 quarters · filed 2023-03-27 | -$130.41M derived: sum of 4 quarters · filed 2023-03-27 | |||
| 2019-12-31 | -$67.97M derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-03-27 | -$93.68M derived: sum of 2 quarters · filed 2023-03-27 | -$124.92M derived: sum of 3 quarters · filed 2023-03-27 | -$141.48M 10-K/A · filed 2023-03-27 | -$110.89M 10-K · filed 2020-02-27 | |||
| 2019-09-30 | -$25.72M 10-Q · filed 2020-11-05 | -$56.95M derived: sum of 2 quarters · filed 2020-11-05 | -$73.52M 10-Q · filed 2020-11-05 | -$99.33M derived: sum of 4 quarters · filed 2020-11-05 | ||||
| 2019-06-30 | -$31.23M 10-Q · filed 2020-08-06 | -$47.80M 10-Q · filed 2020-08-06 | -$73.61M derived: sum of 3 quarters · filed 2020-08-06 | -$96.79M derived: sum of 4 quarters · filed 2020-08-06 | ||||
| 2019-03-31 | -$16.57M 10-Q · filed 2020-05-07 | -$42.38M derived: sum of 2 quarters · filed 2020-05-07 | -$65.55M derived: sum of 3 quarters · filed 2020-05-07 | -$78.81M derived: sum of 4 quarters · filed 2020-05-07 | ||||
| 2018-12-31 | -$25.81M 10-K · filed 2019-02-27 | -$48.99M derived: sum of 2 quarters · filed 2019-11-07 | -$62.24M derived: sum of 3 quarters · filed 2019-11-07 | -$77.87M 10-K · filed 2021-02-24 | ||||
| 2018-09-30 | -$23.18M 10-Q · filed 2019-11-07 | -$36.43M derived: sum of 2 quarters · filed 2019-11-07 | -$52.06M 10-Q · filed 2019-11-07 | -$53.31M derived: sum of 4 quarters · filed 2020-02-27 | ||||
| 2018-06-30 | -$13.26M 10-Q · filed 2019-08-07 | -$28.89M 10-Q · filed 2019-08-07 | -$30.13M derived: sum of 3 quarters · filed 2020-02-27 | -$41.16M derived: sum of 4 quarters · filed 2020-02-27 | ||||
| 2018-03-31 | -$15.63M 10-Q · filed 2019-05-09 | -$16.88M derived: sum of 2 quarters · filed 2020-02-27 | -$27.90M derived: sum of 3 quarters · filed 2020-02-27 | -$53.27M derived: sum of 4 quarters · filed 2020-02-27 | ||||
| 2017-12-31 | -$1.25M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | -$12.27M derived: sum of 2 quarters · filed 2020-02-27 | -$37.65M derived: sum of 3 quarters · filed 2020-02-27 | -$46.26M 10-K · filed 2020-02-27 | ||||
| 2017-09-30 | -$11.03M 10-Q · filed 2018-11-06 | -$36.40M derived: sum of 2 quarters · filed 2018-11-06 | -$45.01M 10-Q · filed 2018-11-06 | -$59.24M derived: sum of 4 quarters · filed 2019-02-27 | ||||
| 2017-06-30 | -$25.37M 10-Q · filed 2018-08-08 | -$33.99M 10-Q · filed 2018-08-08 | -$48.22M derived: sum of 3 quarters · filed 2019-02-27 | -$63.13M derived: sum of 4 quarters · filed 2019-02-27 | ||||
| 2017-03-31 | -$8.61M 10-Q · filed 2018-05-09 | -$22.84M derived: sum of 2 quarters · filed 2019-02-27 | -$37.76M derived: sum of 3 quarters · filed 2019-02-27 | -$52.02M derived: sum of 4 quarters · filed 2019-02-27 | ||||
| 2016-12-31 | -$14.23M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | -$29.15M derived: sum of 2 quarters · filed 2019-02-27 | -$43.40M derived: sum of 3 quarters · filed 2019-02-27 | -$59.59M 10-K · filed 2019-02-27 | ||||
| 2016-09-30 | -$14.92M 10-Q · filed 2017-11-07 | -$29.17M derived: sum of 2 quarters · filed 2017-11-07 | -$45.36M 10-Q · filed 2017-11-07 | -$56.88M derived: sum of 4 quarters · filed 2018-03-07 | ||||
| 2016-06-30 | -$14.26M 10-Q · filed 2017-08-07 | -$30.44M 10-Q · filed 2017-08-07 | -$41.96M derived: sum of 3 quarters · filed 2018-03-07 | -$53.23M derived: sum of 4 quarters · filed 2018-03-07 | ||||
| 2016-03-31 | -$16.18M 10-Q · filed 2017-05-05 | -$27.71M derived: sum of 2 quarters · filed 2018-03-07 | -$38.98M derived: sum of 3 quarters · filed 2018-03-07 | -$44.52M derived: sum of 4 quarters · filed 2018-03-07 | ||||
| 2015-12-31 | -$11.52M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-07 | -$22.79M derived: sum of 2 quarters · filed 2018-03-07 | -$28.34M derived: sum of 3 quarters · filed 2018-03-07 | -$33.20M 10-K · filed 2018-03-07 | ||||
| 2015-09-30 | -$11.27M 10-Q · filed 2016-11-03 | -$16.81M derived: sum of 2 quarters · filed 2016-11-03 | -$21.68M 10-Q · filed 2016-11-03 | -$26.34M derived: sum of 4 quarters · filed 2017-03-02 | ||||
| 2015-06-30 | -$5.54M 10-Q · filed 2016-08-03 | -$10.41M 10-Q · filed 2016-08-03 | -$15.07M derived: sum of 3 quarters · filed 2017-03-02 | -$18.53M derived: sum of 4 quarters · filed 2017-03-02 | ||||
| 2015-03-31 | -$4.87M 10-Q · filed 2016-05-06 | -$9.53M derived: sum of 2 quarters · filed 2017-03-02 | -$12.99M derived: sum of 3 quarters · filed 2017-03-02 | |||||
| 2014-12-31 | -$4.66M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-02 | -$8.12M derived: sum of 2 quarters · filed 2017-03-02 | -$29.77M 10-K · filed 2017-03-02 | |||||
| 2014-09-30 | -$3.46M 10-Q · filed 2015-11-23 | -$25.11M 10-Q · filed 2015-11-23 | ||||||
| 2013-12-31 | -$14.96M 10-K · filed 2016-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B |